Scientific Publications by FDA Staff
Cardiovasc Toxicol 2013 Feb 9 [Epub ahead of print]
Cardiovascular Toxicity of Citrus aurantium in Exercised Rats.
Hansen DK, George NI, White GE, Abdel-Rahman A, Pellicore LS, Fabricant D
When safety concerns forced the removal of ephedra from the market, other botanicals, including Citrus aurantium or bitter orange (BO) were used as replacements. A major component of the BO extract is synephrine, a chemical that is structurally similar to ephedrine. Because ephedrine has cardiovascular effects that may be exacerbated during physical exercise, the purpose of this study was to determine whether extracts containing synephrine produced adverse effects on the cardiovascular system in exercising rats. Sprague-Dawley rats were dosed daily by gavage for 28 days with 10 or 50 mg of synephrine/kg body weight from one of two different extracts; caffeine was added to some doses. The rats ran on a treadmill for 30 min/day, 3 days/week. Heart rate, blood pressure, body temperature, and QT interval were monitored. Both doses of both extracts significantly increased systolic and diastolic blood pressure for up to 8 h after dosing. Effects on heart rate and body temperature appeared to be due primarily to the effects of caffeine. These data suggest that the combination of synephrine, caffeine, and exercise can have significant effects on blood pressure and do not appear to be effective in decreasing food consumption or body weight.
|Category: Journal Article|
|PubMed ID: #23397375||DOI: 10.1007/s12012-013-9199-x|
|Includes FDA Authors from Scientific Area(s): Toxicological Research Food Drugs|
|Entry Created: 2013-02-12|